As obesity rates climb worldwide, so does the demand for weight-loss medications like Novo Nordisk's NVO Ozempic and Eli Lilly And Company's LLY Mounjaro.…
The increasing demand for weight-loss drugs such as Novo Nordisk s Ozempic has led to a rise in counterfeit versions of these medications. Law enforcement agencies, anti-counterfeiting organizations, and public health officials are collaborating to combat this issue. The popularity of weight-loss drugs has made them a target for criminal organizations. Novo Nordisk and Eli Lilly, the manufacturers of these drugs, are working with various agencies to identify and deter counterfeit products.
Extraordinary demand for Novo Nordisk’s Ozempic and other drugs used for weight-loss is fueling a global surge in counterfeit versions, according to Reuters interviews with law enforcement, anti-counterfeiting and public health officials. The U.S.-based Pharmaceutical Security Institute (PSI), an industry-backed organization that counts drugmakers Novo Nordisk and Eli Lilly as members, said it is working with agencies, including Europol, Interpol and U.S. Homeland Security, as well as companies that help identify counterfeit products such as Israel’s BrandShield.
The Pharmaceutical Security Institute said it is working with agencies, including Europol, Interpol and U.S. Homeland Security, as well as companies that help identify counterfeit products